Open AccessFinancial impact of the hospital pharmacy’s participation in clinical trials
Author(s) -
Irene López-Rico,
Roser Vives,
Miquel Cruel,
Carla Cerdan,
Anisi Moron-Besolí,
Miguel Ruiz,
Victor José de Pedro,
Mònica Gómez-Valent
Publication year - 2021
Publication title -
european journal of hospital pharmacy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.313
H-Index - 14
eISSN - 2047-9964
pISSN - 2047-9956
DOI - 10.1136/ejhpharm-2020-002601
Subject(s) - medicine , pharmacy , clinical trial , indirect costs , financial compensation , compensation (psychology) , observational study , finance , revenue , emergency medicine , family medicine , business , accounting , psychology , psychoanalysis
To estimate the cost of the hospital pharmacy's participation in clinical trials (CTs) and to compare it to the amount received in compensation from sponsors.To analyse the financial impact of CTs that end without recruiting any patients and without any financial compensation from promoters.